Study of Symptoms and Functional Outcomes in Adults Treated for Paranasal Sinus, Nasopharyngeal, and Skull Base Tumors

What this Trial Is About

This research aims to understand the symptoms and changes experienced by patients treated for sinonasal, nasopharyngeal, and skull base tumors. It focuses on survivors of both benign and malignant tumors in these areas, estimating how often and how severe adverse and functional outcomes are. The study also looks at health-promoting behaviors during survivorship and seeks to identify factors that affect these outcomes. A database will be created to collect demographic, clinical, recurrence, survival, functional, and patient-reported outcome information for these patients. Participants will undergo standard care assessments that include tests related to hormone levels, hearing, eye health, dental and jaw function, and speech and swallowing abilities. These evaluations are part of the behavioral interventions used to monitor patients function throughout the study. During the study, researchers will assess patients using the MD Anderson Symptom Inventory Head and Neck Module to measure symptoms over about one year. Patients will be monitored for their functional impairments and symptom burden, and data will be collected continuously through study completion. The total duration and detailed monitoring schedule support a thorough understanding of survivorship outcomes.

Assessment of Functional and Symptom Outcomes for Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base Tumors